MedPath

Dendritic cell therapy combined with surgery in mesothelioma (ENSURE)

Phase 1
Conditions
Adult patients diagnosed with resectable epithelioid MPM, following first-line chemotherapy.
Therapeutic area: Diseases [C] - Neoplasms [C04]
Registration Number
CTIS2024-514054-70-00
Lead Sponsor
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: ;Secondary Objective: ;Primary end point(s):
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath